# India Celiac Disease Treatment Market > India Celiac Disease Treatment Market Research Report: Size, Share, Trend Analysis By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End Users (Hospitals and Clinics, Research Centers, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.03% - **2024:** $ 30.53 Million - **2025:** $ 33.9 Million - **2035:** $ 96.54 Million - **Key Players:** AbbVie Inc (US), Gluten Free Holdings Inc (US), General Mills Inc (US), Kraft Heinz Co (US), Nestle SA (CH), Pinnacle Foods Inc (US), Schär AG (IT), The Hain Celestial Group Inc (US) **Report ID:** MRFR/MED/63968-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-celiac-disease-treatment-market-51362 --- ## Market Summary ## **India Celiac Disease Treatment Market Overview** As per MRFR analysis, the India Celiac Disease Treatment Market Size was estimated at 27.47 (USD Million) in 2023. The India Celiac Disease Treatment Market Industry is expected to grow from 30.5(USD Million) in 2024 to 380 (USD Million) by 2035. The India Celiac Disease Treatment Market CAGR (growth rate) is expected to be around 25.774% during the forecast period (2025 - 2035) **Key India Celiac Disease Treatment Market Trends Highlighted** The India Celiac Disease Treatment Market is witnessing significant trends driven by the increasing prevalence of celiac disease among the population. Awareness about gluten-related disorders has grown considerably in recent years, leading to more patients seeking diagnosis and treatment options.  This growing awareness is spurred by information campaigns and increased access to healthcare services, aligning with the government's initiatives to improve healthcare access and education across the country.  The rise in gluten-free product availability in supermarkets and niche health stores also reflects changing consumer preferences and dietary habits. Moreover, there are prospects in creating culturally relevant dietary supplements, as well as gluten-free food items, specially designed for Indian consumers with very particular dietary needs. The Indian food industry is beginning to evolve to serve this market, where manufacturers are working on gluten-free grains and health-oriented products, presenting a worthwhile area for investment, innovation, and entrepreneurship.  Also, with the development of the healthcare framework, there is more focus on dietetics and nutritional counseling for patients with celiac disease. For other recent trends, collaboration between healthcare professionals and the food industry to create awareness campaigns and promote gluten-free diets has gained popularity. The rise of online platforms for purchasing gluten-free products is helping bolster access for consumers throughout India, including rural areas. This shift provides convenience and further educates the population on managing celiac disease through diet, thus improving overall health outcomes and increasing demand in the market. The combination of awareness, evolving consumer needs, and better healthcare access continues to shape the landscape of the celiac disease treatment market in India. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** **India Celiac Disease Treatment Market Drivers** **Rising Prevalence of Celiac Disease in India** The increasing prevalence of Celiac Disease among the Indian population serves as a significant driver for the India Celiac Disease Treatment Market Industry. According to the Indian Society of Gastroenterology, the prevalence rate of Celiac Disease in India is estimated to be around 1 in 100 individuals, which translates to approximately 1.3 crore people affected. This substantial population of individuals requiring diagnosis and treatment intensifies the demand for relevant therapies and interventions. The robust efforts by organizations such as the All India Institute of Medical Sciences (AIIMS) and various health ministries in enhancing awareness and establishing screening programs contribute significantly to diagnosing undiscovered cases. The more awareness and screening that take place, the larger the audience requiring medical treatment, leading to a sharply defined growth trajectory for the market over the coming years. **Advancements in Medical Technology and Research** The rapid advancements in medical technology and Research and Development (R&D) initiatives are propelling the growth of the India Celiac Disease Treatment Market Industry. Innovative treatment options, such as enzyme-based therapies and gluten-free food products, are emerging as effective alternatives to managing the disease. A report by the Department of Biotechnology under the Government of India highlights a notable increase in funding for R&D projects focused on Celiac Disease, which has more than doubled in the last five years.This investment fosters the development of improved treatments and diagnostic tools that cater to the specific needs of Indian patients. Companies like Dr. Reddy's Laboratories are viewing the realm of Celiac Disease treatment as a priority in their R&D agenda, providing a momentum that is substantial for market growth. **Growing Awareness and Education Campaigns** The growing awareness and education campaigns about Celiac Disease are significantly influencing the India Celiac Disease Treatment Market. Government bodies and non-profit organizations are strategically carrying out awareness programs that emphasize the importance of early diagnosis and management of Celiac Disease.  For instance, initiatives led by the Ministry of Health and Family Welfare promote educational workshops and community health outreach, reaching millions.This has resulted in an uptick in the number of diagnosed cases, as shown in recent surveys, indicating that over 60% of those diagnosed have learned about the disease through these initiatives. The increased visibility of Celiac Disease is creating a heightened demand for treatment options amongst the affected population. **India Celiac Disease Treatment Market Segment Insights** **Celiac Disease Treatment Market Treatment Type Insights** The India Celiac Disease Treatment Market demonstrates diverse opportunities through its Treatment Type segment, which is pivotal in addressing the growing awareness and medical management of celiac disease across the nation. Among the various approaches to treatment, the Gluten Free Diet stands out as a cornerstone for managing this autoimmune condition, as it entails a strict avoidance of gluten, thus allowing individuals suffering from celiac disease to lead healthier lives.  Given the cultural significance of food in India and the ubiquity of gluten-containing grains, the emphasis on gluten-free alternatives is increasing, prompting a surge in the availability of gluten-free products. This shift reflects the dietary adjustments needed for patients and responds to the rising consumer demand for healthier and gluten-free food options. Moreover, Vitamin and Minerals Supplements play a critical role in the management of celiac disease, especially as many patients experience malabsorption due to intestinal damage caused by gluten. These supplements provide essential nutrients that individuals may lack due to restricted diets, thereby promoting better health and well-being. The increasing incidence of nutritional deficiencies among patients, coupled with the heightened awareness around health and nutrition, propels the demand for these supplements in India. Medical Therapies, while still under investigation compared to dietary approaches, are gaining attention as effective adjuncts to treatment.  Ongoing Research and Development in this area aim to create innovative therapies that may offer alternatives or complements to dietary restrictions, enhancing the overall quality of life for patients. The evolving landscape of medical therapies provides a promising avenue for future growth as the healthcare ecosystem in India expands to include more comprehensive treatment options for celiac disease.In summary, the Treatment Type for the India Celiac Disease Treatment Market represents a multifaceted approach combining dietary management, nutritional support, and emerging medical therapies.  The increasing approval of gluten-free food products, the recognition of the importance of nutritional supplementation, and ongoing advances in medical therapies highlight the significant and growing landscape of celiac disease management within India. As market growth accelerates, these components work together to create a more integrated approach to treating celiac disease, ensuring that patients can navigate their dietary limitations while maintaining optimal health. The critical interplay of these elements promises to shape the future of celiac disease treatment in India significantly. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** **Celiac Disease Treatment Market End User Insights** The India Celiac Disease Treatment Market is experiencing significant growth, particularly in its End User segment, which includes Hospitals and Clinics, Research Centers, and Others. Hospitals and Clinics play a crucial role in providing diagnostic and treatment services for celiac disease, driven by the increasing awareness and diagnosis rates among the population. With government initiatives aimed at improving healthcare infrastructure, there's a growing inclination towards specialized care in these facilities.  Research Centers hold substantial importance as they contribute to the development of innovative treatment options and therapies, which are essential for advancing patient care and understanding of celiac disease.Additionally, the Others category includes community health organizations and support groups, which are vital in raising awareness and providing education on lifestyle management for patients. The combined efforts of these End Users showcase a commitment to enhancing the quality of care, thereby addressing the increasing prevalence of celiac disease in India. The market growth is further bolstered by rising health consciousness and lifestyle changes among the Indian population, presenting ample opportunities for stakeholders within the India Celiac Disease Treatment Market. **India Celiac Disease Treatment Market Key Players and Competitive Insights** The India Celiac Disease Treatment Market is witnessing significant growth as awareness of celiac disease and gluten-free diets increases among the population. This growth is driven by the rising incidence of celiac disease, an autoimmune disorder that impacts individuals' ability to consume gluten. As a result, various companies are entering the market to provide treatments, gluten-free products, and other services tailored for this particular health issue. The competitive landscape is characterized by a mix of established brands and emerging players focusing on innovative solutions, thereby enhancing the treatment options available to consumers.  The increasing number of health-conscious individuals, along with improved diagnostic techniques, is contributing to the expanding market, with companies striving to establish themselves as key players through product differentiation and strategic collaborations.Nature's Path Foods stands out in the India Celiac Disease Treatment Market due to its commitment to organic, non-GMO, and gluten-free food products. The company has successfully built a strong brand reputation among health-conscious consumers looking for safe and nutritious options. With an extensive range of offerings, including cereals, granolas, and snacks aimed explicitly at those with gluten sensitivity, Nature's Path Foods has cemented its position by focusing on quality and sustainable sourcing.  The company's strengths lie in its highly effective marketing strategies that highlight the health benefits of its products, making it a preferred choice for many gluten-free consumers in India. This focus on healthful living aligns well with the increasing demand for gluten-free alternatives in the region, helping Nature's Path Foods to maintain a competitive edge.Kraft Heinz has made an impactful entry into the India Celiac Disease Treatment Market by offering a variety of gluten-free products under some of its well-known brands.  The company has positioned itself effectively by launching products that cater to the need for safe and enjoyable gluten-free alternatives for celiac disease patients. Key offerings include sauces, snacks, and meal solutions that not only comply with gluten-free standards but also appeal to the taste and preferences of Indian consumers.  Kraft Heinz's strengths include its robust distribution network, which ensures product availability across various regions in India. Additionally, the company's commitment to research and development has led to the formulation of innovative gluten-free products that resonate with the local market. Although specific mergers and acquisitions related to the gluten-free sector are less prominent, Kraft Heinz's broad market presence and strategic partnerships enhance its capacity to compete effectively in this evolving market landscape. **Key Companies in the India Celiac Disease Treatment Market Include** **India Celiac Disease Treatment Market Industry Developments** Recent developments in the India Celiac Disease Treatment Market show significant advancements and growing consumer awareness. Notably, Nature's Path Foods and General Mills have both expanded their gluten-free product lines, contributing to increased availability of treatment options for celiac disease within India. A heightened focus on health and wellness is driving demand for gluten-free foods, evidenced by an array of new product launches in the market. Current affairs reflect a shift towards more health-conscious dietary choices, prompting major companies like Kraft Heinz and Nestlé to invest in gluten-free solutions tailored for the Indian palate.  In terms of market valuation, the Indian gluten-free food market has shown a compounded annual growth rate, fostering optimism among stakeholders regarding profitability and expansion opportunities. Mergers and acquisitions have been relatively quiet in the last months, but previously, in August 2022, Dr. Schär acquired a regional competitor, further solidifying its position in the Indian market. Additionally, the government supports initiatives promoting celiac disease awareness, thereby enhancing market potential for therapeutic options. The continued evolution of gluten-free products and rising consumer awareness reflect a dynamic landscape focused on health-oriented dietary solutions within India. **India Celiac Disease Treatment Market Segmentation Insights** ## Market Drivers ### Growth of the Health Food Sector The expansion of the health food sector in India is significantly influencing the celiac disease-treatment market. With a growing number of consumers prioritizing health and wellness, there is an increasing demand for gluten-free products. This trend is reflected in the market, where gluten-free food sales have seen a substantial rise, projected to reach $1 billion by 2026. The availability of gluten-free alternatives in supermarkets and online platforms is making it easier for individuals with celiac disease to adhere to their dietary restrictions. As more companies enter the market, the variety of gluten-free products is likely to increase, which could enhance patient compliance and satisfaction, ultimately benefiting the celiac disease-treatment market. ### Support from Healthcare Professionals The role of healthcare professionals in advocating for patients with celiac disease is a significant driver for the celiac disease-treatment market. As more doctors and dietitians become educated about celiac disease, they are better equipped to provide accurate diagnoses and effective treatment plans. This professional support is crucial in guiding patients through dietary changes and managing their condition. Furthermore, healthcare providers are increasingly collaborating with food manufacturers to ensure the availability of safe gluten-free products. This partnership may enhance patient outcomes and satisfaction, thereby fostering growth in the celiac disease-treatment market. The emphasis on patient-centered care is likely to continue influencing treatment approaches and market dynamics. ### Increasing Awareness of Celiac Disease The rising awareness of celiac disease among the Indian population is a crucial driver for the celiac disease-treatment market. Educational campaigns and health initiatives by various organizations have led to a better understanding of the disease, its symptoms, and the importance of a gluten-free diet. This heightened awareness is likely to result in more individuals seeking diagnosis and treatment, thereby expanding the market. As of 2025, it is estimated that approximately 1 in 100 individuals in India are affected by celiac disease, indicating a significant potential patient base. Consequently, healthcare providers are increasingly focusing on celiac disease, which may lead to enhanced treatment options and support services, further propelling the market's growth. ### Advancements in Diagnostic Technologies Technological advancements in diagnostic methods for celiac disease are playing a pivotal role in shaping the celiac disease-treatment market. Improved testing techniques, such as genetic testing and advanced serological tests, are enabling quicker and more accurate diagnoses. This is particularly relevant in India, where many cases remain undiagnosed due to a lack of awareness and access to reliable testing. As diagnostic capabilities improve, it is anticipated that more individuals will be identified and treated for celiac disease, thereby expanding the market. The introduction of point-of-care testing could further streamline the diagnostic process, making it more accessible and efficient for patients across the country. ### Rising Incidence of Autoimmune Disorders The increasing incidence of autoimmune disorders in India is contributing to the growth of the celiac disease-treatment market. Celiac disease is classified as an autoimmune condition, and its prevalence appears to be rising alongside other autoimmune diseases. Factors such as environmental changes, dietary habits, and genetic predisposition may be influencing this trend. As awareness of autoimmune disorders grows, healthcare professionals are more likely to consider celiac disease in their differential diagnoses. This shift could lead to an increase in the number of diagnosed cases, thereby driving demand for treatment options and support services within the celiac disease-treatment market. ## Future Outlook The [Celiac Disease Treatment Market](https://www.marketresearchfuture.com/reports/celiac-disease-treatment-market-8474) is projected to grow at 11.03% CAGR from 2025 to 2035, driven by increasing awareness, innovative therapies, and rising diagnosis rates. **New opportunities:** - Development of gluten-free product lines for local markets. - Investment in telehealth platforms for remote patient management. - Partnerships with food manufacturers for gluten-free certification programs. By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and enhanced treatment options. ## Segment Insights ### By Treatment Type: Gluten Free Diet (Largest) vs. Vitamin and Minerals Supplements (Fastest-Growing) In the India celiac disease-treatment market, the segment distribution reveals that the Gluten Free Diet holds the largest market share, indicating its crucial role as a fundamental treatment approach. Meanwhile, Vitamin and Minerals Supplements are gaining traction, showcasing significant demand as patients seek complementary treatments to enhance their nutritional intake while managing symptoms. Growth trends within this segment are influenced by increasing awareness about celiac disease and the rising number of diagnosed cases. The Gluten Free Diet remains a staple for patients, while the demand for Vitamin and Minerals Supplements is surging, driven by the need to address deficiencies often associated with celiac disease. Medical therapies are expected to gradually emerge as advancements occur, highlighting an evolving treatment landscape. Gluten Free Diet (Dominant) vs. Vitamin and Minerals Supplements (Emerging) The Gluten Free Diet serves as the dominant treatment strategy in managing celiac disease, aiming to eliminate gluten from the patient's diet, thereby alleviating symptoms and promoting intestinal healing. Its established presence in the market is reinforced by a strong base of patient adherence. Conversely, Vitamin and Minerals Supplements are emerging as a vital ancillary option for patients, addressing common nutritional deficiencies related to the disease. As the demand for holistic management solutions grows, these supplements are gaining popularity, catering to patients seeking to enhance their overall health. This combination of a foundational diet and supplementary products characterizes a comprehensive approach to managing celiac disease effectively. ### By End User: Hospitals and Clinics (Largest) vs. Research Centers (Fastest-Growing) The India celiac disease-treatment market is significantly influenced by the end user segments, with hospitals and clinics holding the largest share due to their pivotal role in providing treatment and patient care. These facilities are well-equipped with the necessary resources, expert medical staff, and integrated care systems that cater to the growing number of celiac disease patients. On the other hand, research centers are making notable contributions and are emerging as critical players in the market, exploring innovative treatments and therapies, thereby expanding their share steadily. The growth trends within this segment are driven by increasing awareness and diagnosis of celiac disease, which in turn boosts demand for effective treatment solutions. Hospitals and clinics are expanding their service offerings, which fosters an increase in patient visits. Meanwhile, research centers are prioritizing R&D efforts to enhance treatment methodologies, leading to their rapid growth. Additionally, collaborations with pharmaceutical companies to develop new therapies are further accelerating the expansion of research centers. Hospitals and Clinics (Dominant) vs. Research Centers (Emerging) Hospitals and clinics represent the dominant force in the India celiac disease-treatment market, characterized by their comprehensive healthcare services, access to advanced diagnostic tools, and patient management capabilities. These institutions not only provide conventional treatment but also focus on patient education, dietary guidance, and long-term management. The emergence of research centers indicates a growing emphasis on innovation in treatment approaches; these centers are crucial in conducting trials and developing new therapeutic options. Their integrated approach allows for the exploration of alternative treatments, positioning them as vital contributors to the celiac disease landscape, fostering a deeper understanding of the disorder while enhancing patient care solutions. ## Competitive Benchmarking The celiac disease-treatment market in India is characterized by a dynamic competitive landscape, driven by increasing awareness of gluten intolerance and the rising prevalence of celiac disease. Key players are actively engaging in strategies that emphasize innovation, regional expansion, and partnerships to enhance their market presence. Companies such as AbbVie Inc (US), Schär AG (IT), and Nestle SA (CH) are at the forefront, leveraging their extensive product portfolios and research capabilities to cater to the growing demand for gluten-free products. Their collective strategies not only shape the competitive environment but also indicate a shift towards more specialized offerings tailored to consumer needs.In terms of business tactics, localizing manufacturing and optimizing supply chains appear to be critical for success in this market. The competitive structure is moderately fragmented, with several players vying for market share. However, the influence of major companies like Kraft Heinz Co (US) and General Mills Inc (US) is substantial, as they continue to innovate and expand their product lines, thereby setting benchmarks for quality and availability in the celiac disease-treatment sector. In October AbbVie Inc (US) announced a strategic partnership with a local Indian firm to enhance the distribution of its gluten-free product line. This move is significant as it not only facilitates better market penetration but also aligns with the growing trend of localized supply chains, which can lead to reduced costs and improved service delivery. Such partnerships are likely to enhance AbbVie’s competitive edge in a market that is becoming increasingly reliant on local sourcing and distribution. In September Schär AG (IT) launched a new range of gluten-free snacks specifically designed for the Indian palate. This product line is noteworthy as it reflects the company's commitment to innovation and responsiveness to local consumer preferences. By tailoring products to meet regional tastes, Schär is positioning itself as a leader in the niche market of gluten-free foods, potentially increasing its market share in India. In August Nestle SA (CH) expanded its gluten-free offerings by introducing a new line of fortified gluten-free cereals aimed at children. This strategic move is particularly important as it targets a demographic that is often overlooked in the gluten-free segment. By focusing on nutritional value and appealing to health-conscious parents, Nestle is likely to strengthen its brand loyalty and capture a larger share of the market. As of November current trends in the celiac disease-treatment market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development and marketing strategies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing supply chain efficiencies. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technology, and reliability in supply chains. This transition underscores the importance of adapting to consumer demands and market dynamics in a rapidly changing environment. ## Recent News & Developments Recent developments in the India Celiac Disease Treatment Market show significant advancements and growing consumer awareness. Notably, Nature's Path Foods and General Mills have both expanded their gluten-free product lines, contributing to increased availability of treatment options for celiac disease within India. A heightened focus on health and wellness is driving demand for gluten-free foods, evidenced by an array of new product launches in the market. Current affairs reflect a shift towards more health-conscious dietary choices, prompting major companies like Kraft Heinz and Nestlé to invest in gluten-free solutions tailored for the Indian palate.  In terms of market valuation, the Indian gluten-free food market has shown a compounded annual growth rate, fostering optimism among stakeholders regarding profitability and expansion opportunities. Mergers and acquisitions have been relatively quiet in the last months, but previously, in August 2022, Dr. Schär acquired a regional competitor, further solidifying its position in the Indian market. Additionally, the government supports initiatives promoting celiac disease awareness, thereby enhancing market potential for therapeutic options. The continued evolution of gluten-free products and rising consumer awareness reflect a dynamic landscape focused on health-oriented dietary solutions within India. ## Report Scope | MARKET SIZE 2024 | 30.53(USD Million) | | --- | --- | | MARKET SIZE 2025 | 33.9(USD Million) | | MARKET SIZE 2035 | 96.54(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.03% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | AbbVie Inc (US), Gluten Free Holdings Inc (US), General Mills Inc (US), Kraft Heinz Co (US), Nestle SA (CH), Pinnacle Foods Inc (US), Schär AG (IT), The Hain Celestial Group Inc (US) | | Segments Covered | Treatment Type, End User | | Key Market Opportunities | Emerging gluten-free product innovations cater to increasing consumer demand in the celiac disease-treatment market. | | Key Market Dynamics | Rising demand for gluten-free products drives innovation in celiac disease treatment options and consumer awareness in India. | | Countries Covered | India | ## Frequently Asked Questions **Q: What was the overall market valuation of the India celiac disease-treatment market in 2024?** A: The overall market valuation was $30.53 Million in 2024. **Q: What is the projected market valuation for the India celiac disease-treatment market by 2035?** A: The projected valuation for 2035 is $96.54 Million. **Q: What is the expected CAGR for the India celiac disease-treatment market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 11.03%. **Q: Which treatment type segment had the highest valuation in 2024?** A: The Gluten Free Diet segment had the highest valuation of $12.21 Million in 2024. **Q: What are the key players in the India celiac disease-treatment market?** A: Key players include AbbVie Inc, Gluten Free Holdings Inc, General Mills Inc, Kraft Heinz Co, Nestle SA, Pinnacle Foods Inc, Schär AG, and The Hain Celestial Group Inc. **Q: What was the valuation of the Vitamin and Minerals Supplements segment in 2024?** A: The valuation of the Vitamin and Minerals Supplements segment was $9.16 Million in 2024. **Q: Which end user segment is projected to grow significantly by 2035?** A: The Hospitals and Clinics segment is projected to grow significantly, with a valuation of $38.56 Million in 2035. **Q: What was the valuation of the Medical Therapies segment in 2024?** A: The Medical Therapies segment had a valuation of $9.16 Million in 2024. **Q: How does the valuation of Research Centers compare to other end user segments in 2024?** A: The Research Centers segment had a valuation of $9.14 Million, indicating a competitive position among other end user segments. **Q: What is the projected growth trend for the Gluten Free Diet segment by 2035?** A: The Gluten Free Diet segment is projected to reach $38.56 Million by 2035, indicating robust growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-celiac-disease-treatment-market-51362*